Home Podcasts Welcome to Supply-Chain360, your all-in-one source for actual insights into the world of SCM!
Welcome to Supply-Chain360, your all-in-one source for actual insights into the world of SCM!

Welcome to Supply-Chain360, your all-in-one source for actual insights into the world of SCM!

Ralph Leyendecker 21 Episodes Mar 15, 2026

This podcast explores the latest innovations, technologies, and strategies transforming the global supply chain landscape. It covers topics from BANI to generative AI, automation, sustainability, and risk management. The show features in-depth discussions, expert interviews, and actionable tips for professionals and enthusiasts alike. Whether you're a supply chain professional or just curious, it provides insights to optimize operations and learn something new.

Episodes

Chokepoints After Davos:  What Great-Power Politics Now Means for Real Supply Chains
Chokepoints After Davos: What Great-Power Politics Now Means for Real Supply Chains Mar 15, 2026 487 In this episode, I follow up on Davos 2026 by shifting from speeches and symbolism to the physical realities of global supply chains. The focus is on chokepoints: the Red Sea, Suez, Hormuz, and Taiwan, and on what happens when great-power politics starts to narrow the corridors, systems, and dependencies that modern industries rely on.I look at how recent developments have moved from rhetoric into
After Davos: Great-Power Theater, Middle-Power Strategy, and Pharma Supply Chains
After Davos: Great-Power Theater, Middle-Power Strategy, and Pharma Supply Chains Jan 23, 2026 1028 In this episode, I look at Davos 2026 not as a media show, but as a live stress test of the global order.From Merz’ “age of great powers” narrative to Trump’s tariff threats, Greenland remarks, and pressure over U.S. bonds, Davos made one thing clear: the world is being run more openly as a great-power game again, and middle powers, especially in Europe, are caught in the squeeze.I translate this
From Country Crisis to Risk Portfolio – How Pharma Supply Chains should think about Geopolitics
From Country Crisis to Risk Portfolio – How Pharma Supply Chains should think about Geopolitics Jan 19, 2026 913 In this episode, I move beyond “one crisis at a time” and look at geopolitics through the lens of a risk portfolio for pharma and med-tech supply chains. Starting from recent events like Venezuela, the Red Sea, Taiwan, and Europe’s energy debate, I sketch a simple way to map exposure versus geopolitical fragility – not as a theoretical exercise, but as a practical tool for network and governance d
Venezuela and the BANI World – Implications for Health and Pharma Supply Chains
Venezuela and the BANI World – Implications for Health and Pharma Supply Chains Jan 5, 2026 713 In this episode, I unpack the recent U.S. military operation that led to Nicolás Maduro’s capture and ongoing narco-terrorism proceedings in New York, and look at what this actually means for health and pharma supply chains in and around Venezuela.Rather than debating the politics, I focus on access to medicines, sanctions and logistics friction, and two working scenarios: a managed transition wit
Holiday Message – Merry Christmas and see you in 2026!
Holiday Message – Merry Christmas and see you in 2026! Dec 22, 2025 89 This short holiday episode is a quick thank-you from me to you before I step away for a year-end break. I share a few reflections on this past year in pharma supply chains and what’s coming next for the podcast, then hit pause until the new year.Wishing you a Merry Christmas, and a healthy start into the new year. See you soon in the next season of Supply Chain 360.
From Signals to Action – SOPs and Response Playbooks in Pharma Disruption
From Signals to Action – SOPs and Response Playbooks in Pharma Disruption Dec 15, 2025 550 In this episode of Supply Chain 360, we complete the arc from scenarios to signals to action. After building an early-warning radar for your pharma supply chain, the next question is: what happens when a signal actually flashes red?We explore how to turn early warnings into fast, coordinated responses using lean, scenario-specific SOPs – response playbooks. Instead of long policy documents, these
From Scenarios to Signals – Building an Early-Warning System for Pharma Supply Chains
From Scenarios to Signals – Building an Early-Warning System for Pharma Supply Chains Dec 8, 2025 531 In this episode of Supply Chain 360, we move one step further along the BANI journey: from imagining possible futures to actually seeing them coming.Building on the previous episode on scenario planning, we explore how pharma organizations can turn scenarios into a practical early-warning system – a simple risk radar that helps you act before disruption fully hits.We look at how to define meaningf
From Gut Feeling to Scenarios – Preparing your Pharma Supply Chain for the Unexpected
From Gut Feeling to Scenarios – Preparing your Pharma Supply Chain for the Unexpected Dec 1, 2025 434 In this episode of Supply Chain 360, we move from forecasting to future-proofing. Instead of asking “What’s the plan?”, we ask a more powerful question: “What if?”We explore how simple, practical scenario planning can help pharma supply chains prepare for the unexpected. From export restrictions and supplier failures to regulatory changes or a sudden surge in demand when a new use for a drug is ap
Leading in the BANI Decade — How Supply Chains Evolve When Leaders Do
Leading in the BANI Decade — How Supply Chains Evolve When Leaders Do Nov 24, 2025 278 In this final episode of the BANI mini-series on Supply Chain 360, we shift the focus from systems to the people who run them: leaders.We revisit what it means to operate in a world that is brittle, anxious, nonlinear, and incomprehensible, and explore why supply chains only become truly viable when leadership mindsets evolve. This episode looks at how the best leaders move from control to composu
White Swans in Plain Sight — Europe’s Industrial Migration and What It Means for Pharma
White Swans in Plain Sight — Europe’s Industrial Migration and What It Means for Pharma Nov 17, 2025 313 In this episode of Supply Chain 360, part of the BANI mini-series, we explore a major shift that isn’t a sudden shock or black-swan event, but a white swan: a visible, predictable transformation that’s already reshaping Europe’s industrial landscape.Recent data shows that around 70% of energy-intensive companies are moving investments out of Germany, driven by rising energy costs, CO₂ pricing, pol
Enablement — Empowering People and Systems to Adapt Faster than Disruption
Enablement — Empowering People and Systems to Adapt Faster than Disruption Nov 10, 2025 281 In this episode of Supply Chain 360, part of the ongoing BANI mini-series, we explore the fourth and final CORE pillar: Enablement - the force that turns strategy into motion.In a world that’s brittle, anxious, nonlinear, and incomprehensible, enablement is what transforms information into action. It’s not just about tools or training, it’s about trust, confidence, and culture. When people are emp
Risk — Intelligence Over Insurance in Pharma Supply Chains
Risk — Intelligence Over Insurance in Pharma Supply Chains Nov 3, 2025 248 In this episode of Supply Chain 360, part of our BANI mini-series, we unpack the third CORE pillar: Risk. In a world that’s brittle, anxious, nonlinear, and incomprehensible, traditional “risk management” as a checklist or insurance policy isn’t enough. Today’s disruptions, cyber events, trade shifts, API shortages, extreme weather, don’t arrive one at a time; they overlap, cascade, and amplify.We

Recommended